Life sciences companies continued to be popular targets of securities fraud class action lawsuits filed in 2016, and prudent life sciences companies should take heed of the results of this year’s decisions. In 2016,...more
3/9/2017
/ Antitrust Violations ,
Class Action ,
Drug Pricing ,
False Statements ,
FDA Approval ,
Generic Drugs ,
Life Sciences ,
Material Misrepresentation ,
Omissions ,
Popular ,
Price-Fixing ,
Promotional Items ,
Risk Mitigation ,
Securities Fraud ,
Stock Drop Litigation
Publicly Traded Life Sciences Companies in the United States Are an Increasingly Popular Target of Securities Fraud Class Action Lawsuits -
The past year was particularly noteworthy with respect to the relative number...more
3/19/2015
/ Biotechnology ,
Class Action ,
Compliance ,
Disclosure Requirements ,
Insider Trading ,
Life Sciences ,
Medical Devices ,
Misrepresentation ,
Pharmaceutical Industry ,
Popular ,
Publicly-Traded Companies ,
Rule 10b-5 ,
Securities Fraud ,
Surveys
Publicly Traded Life Sciences Companies in the United States Remain an Increasingly Popular Target of Securities Fraud Class Action Lawsuits:
The past year was particularly noteworthy with respect to the absolute and...more